HDL cholesterol enhancers (Wyeth)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHDL cholesterol enhancers (Wyeth)
Drug Alias NameHDL-C enhancers (Wyeth)WAY-135433
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHDL cholesterol enhancers
TargetsUpdating
Therapy Area/IndicationsAtherosclerosisCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Research
Active IndicationsN/A
Inactive IndicationsAtherosclerosisCoronary Artery Disease

Other Information

ATC CodeN/A
Related LinksN/A